SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ekman S) "

Sökning: WFRF:(Ekman S)

  • Resultat 61-70 av 371
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  •  
62.
  •  
63.
  •  
64.
  •  
65.
  • Gadea, A., et al. (författare)
  • Observation of Ni-54 : Cross-conjugate symmetry in f(7/2) mirror energy differences
  • 2006
  • Ingår i: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 97:15, s. 152501-
  • Tidskriftsartikel (refereegranskat)abstract
    • Gamma decays from excited states up to J(pi)=6(+) in the N=Z-2 nucleus Ni-54 have been identified for the first time. Level energies are compared with those of the isobars Co-54 and Fe-54 and of the cross-conjugate nuclei of mass A=42. The good but puzzling f(7/2) cross-conjugate symmetry in mirror and triplet energy differences is analyzed. Shell model calculations reproduce the new data but the necessary nuclear charge-dependent phenomenology is not fully explained by modern nucleon-nucleon potentials.
  •  
66.
  •  
67.
  •  
68.
  •  
69.
  • Jendle, Johan, 1963-, et al. (författare)
  • Switching to insulin degludec is a cost-saving therapy for patients with type 1 and type 2 diabetes in the Swedish setting based on real world data
  • 2019
  • Ingår i: Value in Health. - : Elsevier. - 1098-3015 .- 1524-4733. ; 22:Suppl. 3, s. 575-576
  • Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
    • Objectives: The Europe-based, prospective, observational ReFLeCT study recently showed that switching to the ultralong-acting basal insulin analogue degludec (IDeg) was associated with improved glycemic control and reductions in hypoglycemic events versus previous basal insulin therapies in patients with type 1 (T1D) or type 2 diabetes (T2D). The present analysis aimed to assess the impact of thesefindings on long-term cost-effectiveness outcomes in the Swedish setting.Methods: Cost-effectiveness was evaluated separately in patients with T1D and T2D over a 50-year time horizon using the IQVIA CORE Diabetes Model (version 9.0). Patients were assumed to receive IDeg or continue previous insulin therapy (with or without bolus insulin) for 5 years, before all patients intensified to insulin degludec plus bolus insulin for the remainder of their lifetimes. Baseline cohort characteristics were sourced from ReFLeCT where possible. Treatment effects on initiation of IDeg were based on data from ReFLeCT. Costs were estimated from a Swedish societal perspective and expressed in 2018 Swedish krona (SEK).Results: IDeg was associated with improvements in quality-adjusted life expectancy of 0.14 and 0.07 quality-adjusted life years versus continuation of previous insulin therapy in patients with T1D and T2D, respectively, resulting from improved glycemic control and fewer hypoglycemic events. Combined direct and indirect costs were estimated to be SEK 137,020 and SEK 2,009 lower for insulin degludec versus previous insulin therapy in patients with T1D and T2D, respectively, with higher treatment costs offset by cos tsavings from avoidance of diabetes-related complications. IDeg was therefore considered dominant versus continuation of previous insulin therapies for the treatment of both T1D and T2D.Conclusions: Based on real-world evidence, IDeg represents an effective and cost-saving treatment option versus other basal insulin therapies for patients with T1D and T2D in Sweden.
  •  
70.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 61-70 av 371
Typ av publikation
tidskriftsartikel (272)
konferensbidrag (80)
rapport (7)
annan publikation (6)
bok (2)
forskningsöversikt (2)
visa fler...
samlingsverk (redaktörskap) (1)
bokkapitel (1)
visa färre...
Typ av innehåll
refereegranskat (273)
övrigt vetenskapligt/konstnärligt (97)
populärvet., debatt m.m. (1)
Författare/redaktör
Ekman, S (122)
Tsakonas, G (24)
Ekman, Jörgen (21)
Lewensohn, R. (21)
Brustugun, OT (19)
Ekman, M (17)
visa fler...
de Petris, L (17)
Ekman, P (17)
Ekman, Annica M. L. (16)
Rudolph, Dirk (15)
Hydbring, P (15)
Bergqvist, M. (13)
Fahlander, Claes (13)
Ekman, Inger, 1952 (13)
Carpenter, M P (12)
Seweryniak, D. (12)
Ekman, J (12)
Ragnarsson, Oskar, 1 ... (11)
Sarantites, D. G. (11)
Rosenlund, M (11)
Ekman-Ordeberg, G (11)
du Rietz, Rickard (10)
Burman, Pia (10)
Olsson, Daniel S, 19 ... (10)
Charity, R. J. (10)
Reviol, W. (10)
Planck, M. (10)
Viktorsson, K. (9)
Dahlqvist, Per (9)
Ekman, Bertil (9)
Eide, IJZ (9)
Andersson, Lise-Lott ... (9)
Ekman, B (9)
Sorensen, JB (9)
Zhu, S. (8)
Landén, Mikael, 1966 (8)
Ragnarsson, Ingemar (8)
Bergstrom, S (8)
Chiara, C. J. (8)
Torres, D. A. (8)
Pechenaya, O. L. (8)
Sobotka, L. G. (8)
Ekman, R (8)
Ekman, A (8)
Riipinen, Ilona (7)
Johannsson, Gudmundu ... (7)
Friesland, S (7)
Johansson, Emma (7)
Patel, D. (7)
Andreoiu, C (7)
visa färre...
Lärosäte
Karolinska Institutet (212)
Lunds universitet (57)
Göteborgs universitet (49)
Uppsala universitet (43)
Stockholms universitet (25)
Linköpings universitet (25)
visa fler...
Umeå universitet (19)
Kungliga Tekniska Högskolan (16)
Örebro universitet (15)
Mälardalens universitet (11)
RISE (11)
Malmö universitet (8)
Chalmers tekniska högskola (5)
Blekinge Tekniska Högskola (5)
Sveriges Lantbruksuniversitet (4)
Södertörns högskola (3)
Naturhistoriska riksmuseet (3)
Karlstads universitet (2)
Jönköping University (1)
Naturvårdsverket (1)
Försvarshögskolan (1)
visa färre...
Språk
Engelska (361)
Svenska (9)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (82)
Naturvetenskap (58)
Lantbruksvetenskap (11)
Samhällsvetenskap (10)
Teknik (8)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy